9 days left
Join us for our June Study Day and let national and international experts bring you up to date on the de-escalation of prescription opioids.
The programme includes talks about best practices in Opioid prescribing, the neurobiology of substance abuse and addiction and many other relevant topics.
Organisers: Dr Dev Srivastava, Dr Sumit Gulati and Dr Adam Samways
Please note that this is an in-person event only.
| 09:00 | REGISTRATION |
| 09:20 | Welcome (Dr Dev Srivastava) |
| 09:30 |
Public health impact and contribution of prescription opioids Speaker: Prof Roger Knaggs |
| 10:10 |
Neurobiology of substance abuse and addiction Speaker: Dr Katherine Herlinger |
| 10:50 | BREAK |
| 11:10 |
Best practices in Opioid prescribing Speaker: Dr Sunil Dasari |
| 11:50 |
Factors that increase vulnerability to opioid tolerance, hyperalgesia and overdose Speaker: Prof Timothy Hales |
| 12:30 | Discussion |
| 12:50 | LUNCH BREAK |
| 13:50 |
RCT evidence in opioid de-escalation: the I-WOTCH Trial Speaker: Prof Sam Eldabe |
| 14:30 |
How to perform prescription opioid tapering in secondary care: Issues with complex patients including unintended consequences Speaker: Prof (Dr) Sailesh Mishra & Helen Franklin |
| 15:10 | TEA BREAK |
| 15:30 |
Opioid de-escalation service - A nurse’s view Speaker: Helen Burke |
| 16:10 | DISCUSSION, FEEDBACK & CLOSURE |
Programme subject to change.
Pricing
| Member/ Fellow |
Trainee/ Nurse |
Senior Fellows | Student/ Foundation year | Non Members |
|---|---|---|---|---|
| £195 | £150 | £100 | £60 | £260 |
Sponsor
ESTEVE is an international pharmaceutical innovator and partner with a rich heritage and a purposeful global expansion approach. Medications we supply today help millions of patients worldwide.
ESTEVE has an ambitious vision to become an international proprietary pharma leader in specialty therapeutics. We have a broad and innovative product portfolio in the fields of oncology, COPD and cardiovascular system, neurology, analgesia and ophthalmology.